Revenue
$6.30B
Gross Margin
+78.0%
Operating Margin
+27.6%
Net Margin
+17.3%
Income statement waterfall for Edwards Lifesciences (EW) — TTM through Q1 2026
Net income: $1.09B
Margin breakdown for Edwards Lifesciences (EW) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $6.30B | $6.30B |
| Cost of Revenue | −$1.39B | $4.92B |
| Gross Profit | $4.92B | $4.92B |
| Operating Expenses | −$3.18B | $1.74B |
| Operating Income | $1.74B | $1.74B |
| Other Income / Expense | −$443.00M | $1.30B |
| Pre-tax Income | $1.30B | $1.30B |
| Income Tax | −$224.90M | $1.07B |
| Other Items | $19.70M | $1.09B |
| Net Income | $1.09B | $1.09B |
- Revenue$6.30B
- Cost of Revenue−$1.39B
- Gross Profit$4.92B
- Operating Expenses−$3.18B
- Operating Income$1.74B
- Other Income / Expense−$443.00M
- Pre-tax Income$1.30B
- Income Tax−$224.90M
- Other Items$19.70M
- Net Income$1.09B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement